Viewing Study NCT03370367


Ignite Creation Date: 2025-12-25 @ 12:40 AM
Ignite Modification Date: 2026-04-15 @ 1:05 AM
Study NCT ID: NCT03370367
Status: COMPLETED
Last Update Posted: 2023-06-15
First Post: 2017-12-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Double Blind Phase III Trial of Effects of Low Dose 13-Cisretinoic Acid on Prevention of Second Primaries in Stages I-II Head and Neck Cancer
Sponsor: Eastern Cooperative Oncology Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module References Module